Loading asset research
CalciMedica Inc. Common Stock
CALCNasdaq · USD · StocksQuote as of · Exchange session not verified$1.97
-0.51%
Today
CALC
Loading 1D prices…
Market cap
$13.7M
Volume
98.7K
52w high
$7.2052w low
$0.461Company profile
CalciMedica Inc. Common Stock
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
LA JOLLA, CA, United States
Employees
15
Fiscal year end
1231
CIK
1534133
Session & valuation
Open$1.97
Previous close$1.98
Day high$2.04
Day low$1.92
30-day avg. volume185.4K
Outstanding shares34.1M
Diluted EPS-$1.97
Latest annual period
P/E (trailing)-1.00
P/E (forward)-1.23
Price / book2.23
Beta1.01
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HINDVyome Holdings Inc. Common Stock | $13.8M | $319.7K | -3209.75% | -$4.86 | +0.51% | Buy |
| QNRXQuoin Pharmaceuticals Ltd. American Depositary Shares | $14.1M | $0.00 | — | -$14.80 | +1.59% | Buy |
| SCNXScienture Holdings Inc. Common Stock | $13.1M | $431.6K | -9617.96% | -$2.70 | -5.44% | Buy |
| NRSNNeuroSense Therapeutics Ltd. Ordinary Shares | $13.1M | $0.00 | — | -$0.44 | +3.54% | Buy |
| ENLVEnlivex Ltd. Ordinary Shares | $12.9M | $0.00 | — | $25.48 | -11.85% | Buy |